AGA Medical to Report Third Quarter Earnings on Monday, November 8, 2010

AGA Medical Holdings, Inc. (AGA Medical) (Nasdaq: AGAM) will issue an earnings release to report its third quarter operating results on Monday, November 8, 2010 at approximately 4:30 p.m. ET (3:30 p.m. CT).

On October 20, 2010, St. Jude Medical, Inc. and AGA Medical announced that the Boards of Directors of both companies approved a definitive agreement under which St. Jude Medical, Inc. will acquire all of the outstanding shares of AGA Medical for $20.80 per share in a cash and stock transaction. In light of this announcement, AGA Medical will not host a webcast or conference call to discuss its third quarter operating results.

To access the press release once issued, please go to the investor relations section of the AGA Medical website ( The press release will also be filed on Form 8-K on Tuesday, November 9, 2010 which will be available on the company’s website and on the SEC’s website (

Additional Information about the Proposed Transaction and Where to Find It

In connection with the exchange offer, St. Jude Medical has filed with the SEC a Registration Statement on Form S-4 and a Tender Offer Statement on Schedule TO, and AGA Medical has filed a Solicitation/Recommendation Statement on Schedule 14D-9. INVESTORS AND STOCKHOLDERS ARE URGED TO READ THESE DOCUMENTS CAREFULLY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT ST. JUDE MEDICAL, AGA MEDICAL AND THE PROPOSED TRANSACTION. This news release is for informational purposes only and does not constitute an offer to purchase, or a solicitation of an offer to sell shares of common stock of AGA Medical in any jurisdiction where such activities would be unlawful under the relevant laws in that jurisdiction, nor is it a substitute for the Registration Statement, Schedule TO, and Schedule 14D-9.

Investors and stockholders may obtain free copies of the Registration Statement on Form S-4, the Schedule TO and Schedule 14D-9 as well as other filings containing information about St. Jude Medical and AGA Medical without charge at the SEC’s website (

A free copy of the exchange offer materials are also available on St. Jude Medical’s website at and a copy of the Schedule 14D-9 is available on AGA Medical’s website at Copies of the exchange offer materials may also be obtained free of charge from Georgeson, Inc., the information agent for the exchange offer, by calling toll-free at (877) 278-4774 (brokers and bankers call, (212) 440-9800).

About AGA Medical

AGA Medical, based in Plymouth, Minnesota, is a leading innovator and manufacturer of medical devices for the treatment of structural heart defects and vascular abnormalities. AGA Medical’s AMPLATZER® occlusion devices offer minimally invasive, transcatheter treatments that have been clinically shown to be safe and highly effective in defect closure. AGA Medical is the only manufacturer with occlusion devices approved to close seven different structural heart defects, with leading market positions for each of its devices. More than 1,650 articles supporting the benefits of AMPLATZER products have been published in medical literature. AGA Medical markets its AMPLATZER products in 112 countries worldwide to interventional cardiologists, electrophysiologists, interventional radiologists and vascular surgeons. More information about the company and its products can be found at


AGA Medical Holdings, Inc.
Rachel Ellingson, 763-531-3018
Vice President, Business Development and Investor Relations
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here